doi: 10.1007/BF02175597.
Experimental immunosuppression induced by herpes simplex virus
- PMID: 172950
- DOI: 10.1007/BF02175597
Item in Clipboard
Experimental immunosuppression induced by herpes simplex virus
Arch Virol.
1975.
Abstract
Cell-mediated immune response was studied in experimental herpetic infection in mice. Our data suggest that herpes simplex virus induced immunosuppression in mice. This depression was documented by the unresponsiveness of the lymphocytes to PHA stimulation in vitro and by the enhanced susceptibility of adult mice to Coxsackie B virus infection. Our data also suggest that levamisole, a potent immunostimulant drug, had no effect on the unresponsiveness of the lymphocytes to PHA stimulation.
Similar articles
-
Enhanced host defense mechanisms with levamisole in suckling rats.J Infect Dis. 1975 Nov;132(5):578-81. doi: 10.1093/infdis/132.5.578. J Infect Dis. 1975. PMID: 171323
-
Humoral and cellular immune responses to an envelope-associated antigen of herpes simplex virus.J Infect Dis. 1975 Dec;132(6):660-6. doi: 10.1093/infdis/132.6.660. J Infect Dis. 1975. PMID: 172562
-
Role of antibody in in vitro stimulation of lymphocytes.Indian J Exp Biol. 1983 Nov;21(11):583-4. Indian J Exp Biol. 1983. PMID: 6327508 No abstract available.
-
A review of the identification and titration of antibodies to herpes simplex viruses type 1 and type 2 in human sera.Cancer Res. 1973 Jun;33(6):1469-76. Cancer Res. 1973. PMID: 4352384 Review. No abstract available.
-
The mouse model and understanding immunity to herpes simplex virus.Rev Infect Dis. 1991 Nov-Dec;13 Suppl 11:S935-45. doi: 10.1093/clind/13.supplement_11.s935. Rev Infect Dis. 1991. PMID: 1664131 Review.
Cited by
-
[Therapy of recurrent herpes simplex and its surveillance by MIF determination: with levamisole, BCG, urushiol and herpes antigen vaccine (author's transl)].Arch Dermatol Res (1975). 1977 Apr 27;258(2):151-9. doi: 10.1007/BF00561620. Arch Dermatol Res (1975). 1977. PMID: 141241 German.
-
Efficacy and immune response to rubella subunits vaccines.Arch Virol. 1976;50(3):207-13. doi: 10.1007/BF01320574. Arch Virol. 1976. PMID: 1259596
-
Pathogenetic mechansims of recurrent herpes simplex virus infections.Arch Virol. 1976;51(1-2):1-13. doi: 10.1007/BF01317829. Arch Virol. 1976. PMID: 183627 No abstract available.
-
Efficacy of a nucleic acid free herpetic subunit vaccine.Arch Virol. 1980;65(1):15-23. doi: 10.1007/BF01340536. Arch Virol. 1980. PMID: 6252864
-
Comparison of the humoral and cellular immune response after immunization with live, UV inactivated herpes simplex virus and a subunit vaccine and efficacy of these immunizations.Arch Virol. 1976;52(1-2):29-35. doi: 10.1007/BF01317862. Arch Virol. 1976. PMID: 187150